Atlas Trials

Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC

Clinical trial NCT01088906 · TERMINATED

Trial details

NCT number
NCT01088906
Sponsor
Spanish Lung Cancer Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non Small Cell Lung
Start date
2010-01-01
Primary completion
2014-04-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.